Hair Transplant Surgeon Published Researcher Clinical Studies: What Dr. Keene’s Peer-Reviewed Record Actually Means for Your Treatment Plan

Introduction: Why a Surgeon’s Research Record Belongs in Your Decision-Making Process

Most patients evaluate hair transplant surgeons the same way: by scrolling through before-and-after galleries and reading star ratings. These signals matter, but they leave a critical question unanswered. What has the surgeon actually contributed to the science that makes those results possible?

There is a meaningful difference between a surgeon who performs procedures and a surgeon who publishes peer-reviewed research. The latter has documented, tested, and refined their clinical observations under the scrutiny of independent experts. Those insights do not stay locked in a journal. They become embedded in every consultation and every procedure that surgeon performs.

At Hair Transplant Specialists, Dr. Sharon Keene, M.D., brings exactly this kind of record. She is a Past President of the International Society of Hair Restoration Surgery (ISHRS), serving from 2014 to 2015. She received the 2013 Platinum Follicle Award for outstanding scientific research. Her work appears in the Aesthetic Surgery Journal, Experimental Dermatology, and Hair Transplant Forum International, and she contributed chapters to the fourth and sixth editions of Hair Transplantation, the field’s premier reference textbooks.

This article does not simply list those credentials. Its purpose is to translate each research domain into a concrete, patient-facing advantage, explaining what happens differently in a consultation room because of this work.

The context is worth noting. The global hair transplant market reached roughly $10.74 billion in 2026 and is projected to hit $59.89 billion by 2035. As the field grows rapidly, so does the need for patients to distinguish research-active surgeons from volume-focused clinics. A 2024 bibliometric review from the University of Miami, Florida Atlantic University, Washington University, and McGill University confirmed that published authority in hair transplantation directly correlates with influence on clinical practice and patient outcomes. Research, in other words, is clinically relevant, not merely academic.

What It Actually Means When a Hair Transplant Surgeon Publishes Clinical Research

Peer review is a filter. Before research reaches print, it must be evaluated and validated by independent experts in the field. This is a higher standard than anecdotal clinical experience alone, because a claim must withstand challenge from people who have no reason to agree with it.

This creates an important distinction. A surgeon who only performs procedures answers to their own results. A surgeon who also publishes must achieve outcomes that are reproducible and explainable: techniques that work not just for them but for every surgeon who reads and applies them. That standard demands a level of precision and consistency that procedural volume alone cannot guarantee.

Published findings then translate into practice. Research informs how a surgeon designs a hairline, which patients are good candidates for specific medications, how many grafts can be safely harvested, and how outcomes are honestly framed during counseling. Surgeons who write textbook chapters and organize continuing-education curricula shape how the entire specialty practices. Dr. Keene did precisely this as Chair of the 15th Annual ISHRS Scientific Meeting in 2007, where she organized a curriculum that earned AMA CME certification.

This matters for patient safety, too. According to the 2025 ISHRS Practice Census, 59% of member surgeons reported black-market hair transplant clinics operating in their cities, up from 51% in 2021, and repair cases tied to prior black-market procedures rose to 10% of all repair cases in 2024. A surgeon’s verifiable research record becomes a meaningful safety signal in that environment.

It also resonates with today’s patients. The same census found that 95% of first-time surgical patients in 2024 were aged 20 to 35, a digitally native demographic that actively researches surgeon credentials and publication records before committing.

Research Domain 1: Vitamin D Deficiency and Hair Loss

In July 2022, Dr. Keene published a case report through the ISHRS documenting a correlation between vitamin D deficiency and hair thinning, with regrowth following supplementation. This may sound like a minor detail, but it addresses a real gap in how many consultations are conducted.

Many patients who arrive for a hair transplant consultation have an underlying nutritional or hormonal contributor to their hair loss that has never been identified. A surgeon without this research background may move directly to surgical planning without investigating root causes.

At a consultation informed by this work, a patient is more likely to receive a comprehensive evaluation that considers potential vitamin D deficiency as a contributing or compounding factor, not just a graft count. This matters for outcomes: if a nutritional deficiency is driving hair loss and goes unaddressed, surgical results can be compromised. Identifying and correcting it before or alongside surgery can improve long-term results.

The broader principle is that research-active surgeons approach hair loss as a multifactorial condition, not a single-solution problem. That orientation shapes the depth of every evaluation.

Research Domain 2: Epigenetics, the Androgen Receptor Gene, and Personalized Finasteride Planning

Not everyone responds to finasteride equally, and Dr. Keene’s research helps explain why. Her PubMed-indexed pilot study examined genetic variations in the androgen receptor (AR) gene and their relationship to finasteride response in women with androgenetic alopecia.

The finding, in plain language: women with greater androgen sensitivity, specifically fewer than 24 CAG repeats in the AR gene, were significantly more likely to respond to finasteride at 1 mg per day. Genetics can help predict who will benefit from the medication.

Epigenetics adds another layer. Epigenetic mechanisms, including DNA methylation of the AR gene, influence how hair follicles respond to androgens. This is not only about which genes a patient carries but about how those genes are expressed.

For patients, this changes the treatment conversation. Rather than prescribing finasteride as a one-size-fits-all protocol, a surgeon informed by this research can factor in a patient’s likely response profile, avoiding months of ineffective treatment and enabling more targeted planning.

The significance is not small. A 2025 bibliometric analysis found that the top 100 androgenetic alopecia articles were collectively cited 24,289 times as of July 2024. Research at this level shapes field-wide treatment standards, and Dr. Keene’s contribution places her at the forefront of personalized management. A surgeon who understands why a medication works, or does not work, for a specific patient is far better positioned to counsel on realistic expectations and adjust plans over time.

Research Domain 3: Genetic Testing and Minoxidil Response Prediction

Since 2014, Dr. Keene has been involved in a clinical study to develop a genetic test to predict who will respond to minoxidil, and she became Chief Medical Officer of HairDx.com, the first company to offer genetic testing for androgenetic alopecia.

The underlying science is accessible. Minoxidil response is partly determined by sulfotransferase enzyme levels in hair follicles. Patients with higher sulfotransferase activity are more likely to respond, and this can be assessed through genetic testing.

For patients, this represents a shift away from trial and error. Instead of using minoxidil for months before learning whether it works, a patient at a research-informed consultation may have access to testing that predicts response before committing to a long-term regimen. Hair loss treatment moves from a reactive model (try it and see) to a predictive one (test first and then plan). That is a meaningful quality-of-life improvement and a more efficient path to effective care.

The same research infrastructure that produced the epigenetics study and the genetic testing work positions the practice at the leading edge of individualized hair loss care, a differentiator that purely procedural clinics cannot replicate. This is especially relevant for women, who have historically been underserved by hair loss research. Female surgical patients increased by 16.5% from 2021 to 2024 per the ISHRS, and they benefit disproportionately from a personalized, evidence-based approach to female hair loss causes and diagnosis.

Research Domain 4: Safe FUE Excision Limits and Your Donor Area

Few decisions in hair restoration carry more permanent consequences than how many grafts to harvest from the donor area. Over-harvesting creates visible, uncorrectable thinning in the donor zone.

Dr. Keene co-authored a peer-reviewed publication in Hair Transplant Forum International (Vol. 28, No. 1, Jan/Feb 2018) with William R. Rassman and James A. Harris establishing clinical guidelines for safe FUE graft harvesting to preserve long-term donor aesthetics.

This is not a simple arithmetic question, and a surgeon who has published on it operates from a research-informed framework rather than intuition or procedural habit. The graft recommendation a patient receives is grounded in peer-reviewed evidence.

The connection to patient safety is direct. Repair cases tied to prior black-market procedures rose to 10% of all repair cases in 2024, and many involve donor area thinning from multiple procedures by unqualified practitioners. Dr. Keene’s published guidelines represent the opposite of that approach. As ISHRS President, she also led the society to formally embrace the policy that surgeons must personally perform critical surgical steps, including donor harvesting in FUE, rather than delegating to unlicensed technical staff. That policy directly protects patients from the risks her research addresses.

A surgeon who has studied donor density preservation is thinking about what a patient’s scalp looks like in 20 years, not merely the immediate post-procedure result.

Research Domain 5: Photobiomodulation (LLLT) and Evidence-Based Non-Surgical Care

Dr. Keene critically assessed published device trials for photobiomodulation, also known as low-level light therapy, identifying limitations in existing studies and making evidence-based recommendations for clinical application.

Critically evaluating existing literature, rather than accepting device manufacturer claims at face value, is a quality-gatekeeping function that protects patients from ineffective or overstated treatments. When a surgeon has published a critical assessment of LLLT devices, their recommendation to use or avoid a specific device rests on a rigorous review of the evidence.

Hair Transplant Specialists offers photobiomodulation as part of its non-surgical menu, and patients can be confident that this offering has been evaluated through the same lens that informs all of Dr. Keene’s clinical decisions.

The same evidence-based orientation extends to other adjunct therapies. A 2025 meta-analysis of 43 trials found that PRP used alongside FUE significantly improves density, and a 2024 study reported 99% graft survival with PRP versus 71% without at four months. Surgeons active in the literature are more likely to integrate such evidence-supported adjuncts into their protocols, building comprehensive plans based on what the evidence actually supports.

The Platinum Follicle Award and ISHRS Leadership

The Platinum Follicle Award, given to Dr. Keene by the ISHRS in 2013, recognizes “outstanding achievement in basic scientific or clinically-related research in hair pathophysiology or anatomy as it relates to hair restoration.” It is the field’s highest recognition for research contribution, not procedural volume.

Her tenure as ISHRS Past President from 2014 to 2015 means her peers recognized her as the field’s foremost leader during that period. Her earlier appointment to the ISHRS Evidence-Based Medicine Task Force in 2008 placed her at the intersection of clinical research and field-wide standards, helping define what counts as evidence-based practice for the entire specialty.

These are not honorary titles. They reflect a career of contributions that have shaped how hair restoration is practiced globally. Her textbook chapters in Hair Transplantation, 4th and 6th editions, mean her clinical insights are part of the foundational education of hair restoration surgeons worldwide.

When evaluating surgeons, the question is not only how many procedures they have performed, but whether their work has been validated, peer-reviewed, and recognized by the global medical community. Dr. Keene’s record answers that question definitively.

How Research-Active Surgeons Approach the Consultation Differently

Each domain covered here (vitamin D, epigenetics, genetics, FUE limits, and photobiomodulation) represents a dimension of patient evaluation that a non-research-active surgeon is less likely to incorporate systematically.

A research-informed consultation includes a comprehensive assessment of contributing factors (nutritional, hormonal, and genetic), medication planning shaped by likely response profiles, surgical planning grounded in published safety guidelines, and integration of adjunct therapies supported by current literature.

Expectation management matters here, too. A 2025 narrative review in the Journal of Cosmetic Dermatology noted that patient satisfaction with hair transplantation ranges from 75% to 90%, correlating most closely with expectation management, a skill honed through evidence-based practice rather than volume alone.

The reproducibility standard reinforces all of this. Because published surgeons must achieve explainable, repeatable results, they operate at a higher level of precision. Combined with Dr. Keene’s advocacy for surgeon-performed surgery, patients can expect that critical steps are handled by the credentialed surgeon, not delegated to unlicensed staff.

Understanding the Difference Between a Credential and a Clinical Advantage

Credentials on a website are signals, not explanations. Board certification, society membership, and publication counts tell a patient that a surgeon is legitimate, but they do not describe what happens in the treatment room.

Most clinics list publications in a biography without explaining what was studied, what was found, and how it changed practice. Knowing that Dr. Keene co-authored the peer-reviewed guidelines on safe harvesting limits helps a patient understand why their graft recommendation is grounded in evidence rather than arbitrary judgment. Knowing she has been developing predictive genetic tests for minoxidil response since 2014 explains why a non-surgical plan might include genetic assessment: it reflects a decade of research investment rather than a marketing add-on.

A surgeon’s research record is a window into how they think about hair loss, the questions they ask, the variables they weigh, and the standards they hold themselves to. As the market expands and black-market clinics proliferate, the ability to distinguish research-active surgeons from volume-focused operators becomes an increasingly valuable patient skill.

Conclusion: Research Is Not a Credential, It Is a Clinical Philosophy

Dr. Keene’s publication record is not a footnote to her surgical career. It is the foundation of how she evaluates patients, plans treatments, and makes decisions that affect long-term outcomes.

The five domains map directly onto patient-facing benefits: vitamin D assessment within a comprehensive evaluation, epigenetics-informed finasteride planning, genetic testing for minoxidil response prediction, published safety guidelines for FUE donor preservation, and evidence-based integration of non-surgical therapies. Together, they explain how Hair Transplant Specialists combines academic rigor with personalized care. The research record is what makes the personalization possible, because it supplies the evidence base for individualized decisions.

Choosing a hair transplant surgeon is one of the most consequential aesthetic decisions a person makes. Because surgical results are permanent, the quality of the planning process matters as much as the technical execution. In a market where most clinics compete on before-and-after photos and patient volume, the ability to point to peer-reviewed publications, field-shaping policy contributions, and a decade of genetic research as the basis for clinical decisions is a differentiator no marketing can replicate. It must be earned through the work.

Ready to Experience a Research-Informed Hair Restoration Consultation?

Patients who want to see firsthand how Dr. Keene’s research background shapes evaluation and treatment planning are invited to schedule a consultation with Hair Transplant Specialists.

The consultation is informational and low-pressure. The goal is to understand a patient’s specific hair loss pattern, contributing factors, and personal goals, not to sell a procedure.

The practice serves patients at its Eagan, Minnesota location and can be reached by phone at (651) 393-5399 or through the website at INeedMoreHair.com. Office hours are Monday through Thursday from 9:00 AM to 5:00 PM, Friday from 9:00 AM to 3:00 PM, and Saturday and Sunday by appointment.

Whether a patient is in the early stages of hair loss or has been weighing surgery for years, a consultation with a surgeon who has published on the science of hair restoration is a meaningful first step toward an informed decision, and a clear reflection of the practice’s commitment to evidence-based, patient-centered care.